BAC
Bank of America Corporation
BAC has a slight edge over BHB overall, supported by stronger valuation and stronger modeled upside.
BHB
Bar Harbor Bankshares
BHB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BHB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BHB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BHB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BHB in the historical PE scenario, which offers more potential upside but is not a forecast.
BHB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $31.73 | -23% |
| Fair | 11x | $38.75 | -6.4% |
| Forward | 11x | $41.39 | — |
| Current | 12x | $41.39 | — |
| Expensive | 14x | $45.87 | +11% |
Historical ranges are pointers, not guarantees.
BHB's PE is in its fair range at 12x. On analysts' estimates for next year's earnings, today's price would be 11x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over BHB on the outlook, with more favorable earnings and revenue expectations.
BHB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect BHB's earnings, revenue and profitability to hold roughly steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over BHB on earnings, with more consistent year-over-year improvement.
BHB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.80 | +12% |
| Q3 2026 | $3.39 | +47% |
| Q2 2026 | $2.97 | +16% |
| Q1 2026 | $2.46 | -13% |
| Q4 2025 | $2.31 | -19% |
| Q3 2025 | $2.31 | -17% |
| Q2 2025 | $2.57 | -5.2% |
| Q1 2025 | $2.84 | +3.3% |
| Q4 2024 | $2.84 | -3.7% |
BHB earned $3.39 per share over the past year, up 47% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BHB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $51.6M | +8.5% |
| Q2 2026 | $49.7M | +44% |
| Q1 2026 | $47.3M | +25% |
| Q4 2025 | $48.9M | +27% |
| Q3 2025 | $47.5M | +23% |
| Q2 2025 | $34.5M | -7.6% |
| Q1 2025 | $37.9M | +3.5% |
| Q4 2024 | $38.5M | +2.2% |
BHB's revenue has grown year over year for five quarters in a row: $52M last quarter, up 8.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +16 points |
| Q2 2026 | 39% | +17 points |
| Q1 2026 | 36% | +2.8 points |
| Q4 2025 | 30% | -5.1 points |
| Q3 2025 | 23% | -12 points |
| Q2 2025 | 22% | -13 points |
| Q1 2025 | 33% | -1.1 points |
| Q4 2024 | 35% | +1.8 points |
BHB has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BHB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17.3M | +12% |
| Q2 2026 | $21.8M | +564% |
| Q1 2026 | $3M | -61% |
| Q4 2025 | $17M | +37% |
| Q3 2025 | $15.4M | -31% |
| Q2 2025 | $3.3M | +44% |
| Q1 2025 | $7.8M | -0.9% |
| Q4 2024 | $12.4M | -6.6% |
BHB's free cash flow was $59M over the past year, up 52% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BHB.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BHB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BHB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +19.5K shares |
| 1 year | +3.3% | +544K shares |
| 3 years | +11% | +1.6M shares |
| 5 years | +12% | +1.8M shares |
| Available history | +7.9% | +1.2M shares |
BHB has 17M diluted shares, up 3.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $718,000 |
| Q3 2020 | $6M |
| Q2 2020 | $7.3M |
| Q1 2020 | $130,000 |
| Q4 2019 | $107,000 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BHB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 4.0x | High |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 3.8x | Elevated |
BHB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BHB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.3 | Neutral |
| Stochastic | 68.3 | Neutral |
BHB's weekly RSI is 64 (neutral) and its Stochastic is 68 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BHB on valuation relative to its sector.
BHB PE vs Financial Services Sector
| Metric | BHB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 6.2% below |
| PE % | 64 | 63 | 1 pt above |
BHB is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BHB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.7 | 4.2% above |
| 20 week MA | $39.5 | 4.8% above |
| 50 week MA | $36.1 | 15% above |
| 100 week MA | $33.2 | 25% above |
| 200 week MA | $30.3 | 36% above |
BHB has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
BHB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.4 | $22.1 | -13% |
| 2021 | $22.1 | $29.2 | +32% |
| 2022 | $29.2 | $31.1 | +6.2% |
| 2023 | $31.1 | $29.4 | -5.5% |
| 2024 | $29.4 | $30.3 | +3% |
| 2025 | $30.3 | $31.9 | +5.4% |
| 2026 YTD | $31.9 | $41.4 | +30% |
BHB has the edge over BAC on returns for 2026, with the stronger performance.